Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
615 JPY | -0.65% |
|
+1.49% | -47.53% |
Business Summary
Number of employees: 879
Sales per Business
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 34,343 | 100.0 % | 42,871 | 100.0 % | +24.83% |
Sales per region
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 34,343 | 100.0 % | 42,871 | 100.0 % | +24.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 46 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Yoshio Hiyama
BRD | Director/Board Member | - | 19-03-31 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 20-05-31 |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 16-05-31 |
Toru Ashida
BRD | Director/Board Member | 55 | 13-12-31 |
Masaki Sumiyoshi
HRO | Human Resources Officer | - | - |
Masaya Ichikawa
AUD | Comptroller/Controller/Auditor | - | - |
Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 18-06-26 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Toru Ashida
BRD | Director/Board Member | 55 | 13-12-31 |
Director/Board Member | 71 | 15-05-31 | |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 16-05-31 |
Yutaka Atomi
BRD | Director/Board Member | 79 | - |
Yuko Hayashi
BRD | Director/Board Member | 59 | 18-06-26 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 46 | 03-03-31 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 129,686,308 | 68,696,394 ( 52.97 %) | 4,881,914 ( 3.764 %) | 52.97 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,585,900 | 3.54% | 16,750,825 $ | |
204,000 | 0.54% | 3,933,438 $ |
Company contact information
JCR Pharmaceuticals Co., Ltd.
3-19 Kasuga-cho
659-0021, Ashiya
+81 7 9732 8591
http://www.jcrpharm.co.jp![address JCR Pharmaceuticals Co., Ltd.(4552)](https://cdn.zonebourse.com/static/address/11551531.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.53% | 478M | |
+55.55% | 816B | |
+40.85% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.60% | 238B | |
+1.43% | 222B | |
+13.61% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 4552 Stock
- Company JCR Pharmaceuticals Co., Ltd.